191 related articles for article (PubMed ID: 33254497)
21. Efficacy and safety of long-acting pasireotide in Japanese patients with acromegaly or pituitary gigantism: results from a multicenter, open-label, randomized, phase 2 study.
Tahara S; Murakami M; Kaneko T; Shimatsu A
Endocr J; 2017 Jul; 64(7):735-747. PubMed ID: 28592706
[TBL] [Abstract][Full Text] [Related]
22. Acromegaly and gigantism in the medical literature. Case descriptions in the era before and the early years after the initial publication of Pierre Marie (1886).
de Herder WW
Pituitary; 2009; 12(3):236-44. PubMed ID: 18683056
[TBL] [Abstract][Full Text] [Related]
23. Quantification of specific growth patterns and frequency of the empty sella phenomenon in growth hormone-secreting pituitary adenomas.
Bier G; Hempel JM; Grimm F; Ernemann U; Bender B; Honegger J
Eur J Radiol; 2018 Jul; 104():79-86. PubMed ID: 29857870
[TBL] [Abstract][Full Text] [Related]
24. Pegvisomant treatment in gigantism caused by a growth hormone-secreting giant pituitary adenoma.
Müssig K; Gallwitz B; Honegger J; Strasburger CJ; Bidlingmaier M; Machicao F; Bornemann A; Ranke MB; Häring HU; Petersenn S
Exp Clin Endocrinol Diabetes; 2007 Mar; 115(3):198-202. PubMed ID: 17427111
[TBL] [Abstract][Full Text] [Related]
25. Postoperative GH and Degree of Reduction in IGF-1 Predicts Postoperative Hormonal Remission in Acromegaly.
Cardinal T; Collet C; Wedemeyer M; Singer PA; Weiss M; Zada G; Carmichael JD
Front Endocrinol (Lausanne); 2021; 12():743052. PubMed ID: 34867787
[TBL] [Abstract][Full Text] [Related]
26. Pituitary gigantism: Causes and clinical characteristics.
Rostomyan L; Daly AF; Beckers A
Ann Endocrinol (Paris); 2015 Dec; 76(6):643-9. PubMed ID: 26585365
[TBL] [Abstract][Full Text] [Related]
27. The causes and consequences of pituitary gigantism.
Beckers A; Petrossians P; Hanson J; Daly AF
Nat Rev Endocrinol; 2018 Dec; 14(12):705-720. PubMed ID: 30361628
[TBL] [Abstract][Full Text] [Related]
28. Five-year follow-up of a 13-year-old boy with a pituitary adenoma causing gigantism--effect of octreotide therapy.
Schoof E; Dörr HG; Kiess W; Lüdecke DK; Freitag E; Zindel V; Rascher W; Dötsch J
Horm Res; 2004; 61(4):184-9. PubMed ID: 14739526
[TBL] [Abstract][Full Text] [Related]
29. Surgical Management of Carney Complex-Associated Pituitary Pathology.
Lonser RR; Mehta GU; Kindzelski BA; Ray-Chaudhury A; Vortmeyer AO; Dickerman R; Oldfield EH
Neurosurgery; 2017 May; 80(5):780-786. PubMed ID: 27509071
[TBL] [Abstract][Full Text] [Related]
30. Coexisting diseases modifying each other’s presentation - lack of growth failure in Turner syndrome due to the associated pituitary gigantism.
Dragović T; Đuran Z; Jelić S; Marinković D; Kiković S; Kuzmić-Janković S; Hajduković Z
Vojnosanit Pregl; 2016 Oct; 73(10):961-6. PubMed ID: 29328563
[TBL] [Abstract][Full Text] [Related]
31. Pure endoscopic transsphenoidal surgery for treatment of acromegaly: results of 67 cases treated in a pituitary center.
Gondim JA; Almeida JP; de Albuquerque LA; Gomes E; Schops M; Ferraz T
Neurosurg Focus; 2010 Oct; 29(4):E7. PubMed ID: 20887132
[TBL] [Abstract][Full Text] [Related]
32. Neuroendocrine tumors secreting growth hormone-releasing hormone: Pathophysiological and clinical aspects.
Gola M; Doga M; Bonadonna S; Mazziotti G; Vescovi PP; Giustina A
Pituitary; 2006; 9(3):221-9. PubMed ID: 17036195
[TBL] [Abstract][Full Text] [Related]
33. Ectopic acromegaly due to a GH-secreting pituitary adenoma in the sphenoid sinus: a case report and review of the literature.
Ramírez C; Hernández-Ramirez LC; Espinosa-de-los-Monteros AL; Franco JM; Guinto G; Mercado M
BMC Res Notes; 2013 Oct; 6():411. PubMed ID: 24119925
[TBL] [Abstract][Full Text] [Related]
34. Gigantism: microsurgical treatment by transsphenoidal approach and prognostic factors.
García-Uría Santos M; Fernández Mateos C; Lucas Morante T; García-Uría J
Pituitary; 2023 Feb; 26(1):51-56. PubMed ID: 36335516
[TBL] [Abstract][Full Text] [Related]
35. Growth hormone-secreting adenomas: pathology and cell biology.
Lopes MB
Neurosurg Focus; 2010 Oct; 29(4):E2. PubMed ID: 20887127
[TBL] [Abstract][Full Text] [Related]
36. Ectopic GH-secreting pituitary adenoma of the clivus: systematic literature review of a challenging tumour.
Riccio L; Donofrio CA; Tomacelli G; De Blasi R; Melatini A
Pituitary; 2020 Aug; 23(4):457-466. PubMed ID: 32504302
[TBL] [Abstract][Full Text] [Related]
37. Early descriptions of acromegaly and gigantism and their historical evolution as clinical entities.
Mammis A; Eloy JA; Liu JK
Neurosurg Focus; 2010 Oct; 29(4):E1. PubMed ID: 20887119
[TBL] [Abstract][Full Text] [Related]
38. Metabolic glucose status and pituitary pathology portend therapeutic outcomes in acromegaly.
Cheng S; Al-Agha R; Araujo PB; Serri O; L Asa S; Ezzat S
PLoS One; 2013; 8(9):e73543. PubMed ID: 24039977
[TBL] [Abstract][Full Text] [Related]
39. Growth hormone (GH) secretory dynamics in a case of acromegalic gigantism associated with hyperprolactinemia: nonpulsatile secretion of GH may induce elevated insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 levels.
Yoshida T; Shimatsu A; Sakane N; Hizuka N; Horikawa R; Tanaka T
J Clin Endocrinol Metab; 1996 Jan; 81(1):310-3. PubMed ID: 8550769
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
